InterventionsReview

Glucagon-Like Peptide 1 Receptor Agonists and NAION—A Systematic Review and Meta-analysis

ADA Scientific Sessions 2025 Abstract

The paper

HO C, AYERS A, KOHN MA et al.

ADA Scientific Sessions 2025 Abstract · 13 Jun 2025

Presented at ADA Scientific Sessions 2025 · Late-breaking 1972-LB

doi.org/10.2337/db25-1972-lb

SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
Semaglutide may protect kidneys by reducing vascular resistance
Nature Medicine · 4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
GLP-1 receptor agonists link to lower stroke and Alzheimer risk
Neurology Genetics · 4 Oct 2026